Learn about the CareStart COVID-19 Antigen Home Test for qualitative detection of SARS-CoV-2 nucleocapsid protein antigens from nasal swab samples. Authorized for non-prescription home use, this test provides results in minutes. Positive results indicate the presence of viral antigens, but additional testing may be necessary for infection confirmation. Negative results should be considered in the context of recent exposures and symptoms.
The CareStart COVID-19 Antigen Home Test user manual provides instructions for using the lateral flow immunoassay to detect SARS-CoV-2 antigens. It is authorized for non-prescription home use with self-collected anterior nasal swab samples from individuals aged 14 years or older with symptoms of COVID-19. Positive results should be followed up with additional testing and clinical correlation. Negative results should not be used as the sole basis for patient management decisions.
The CareStart RCHM-02071 Covid-19 Antigen test is an FDA-authorized, lateral flow immunochromatographic assay designed to detect SARS-CoV-2 nucleocapsid protein antigen. This user manual provides instructions for use and important information on interpreting results. Ideal for use in point of care settings by healthcare professionals or trained users.
The CareStart COVID-19 Antigen Test Kit is a lateral flow immunochromatographic assay for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2. It is authorized for use under the Emergency Use Authorization (EUA) and can be used for in vitro diagnostic purposes. The kit is intended for use by medical professionals or trained operators who are proficient in performing tests and trained clinical laboratory personnel or individuals trained in point of care settings.
